PL1699434T3 - Sposób wytwarzania leku - Google Patents

Sposób wytwarzania leku

Info

Publication number
PL1699434T3
PL1699434T3 PL04782768T PL04782768T PL1699434T3 PL 1699434 T3 PL1699434 T3 PL 1699434T3 PL 04782768 T PL04782768 T PL 04782768T PL 04782768 T PL04782768 T PL 04782768T PL 1699434 T3 PL1699434 T3 PL 1699434T3
Authority
PL
Poland
Prior art keywords
agglomerate
active ingredient
primary particles
preparing
carrier
Prior art date
Application number
PL04782768T
Other languages
English (en)
Inventor
Zeng Xian-Ming
Kee Tee Sean
Original Assignee
Norton Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34272843&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1699434(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Norton Healthcare Ltd filed Critical Norton Healthcare Ltd
Publication of PL1699434T3 publication Critical patent/PL1699434T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
PL04782768T 2003-09-02 2004-09-01 Sposób wytwarzania leku PL1699434T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49958203P 2003-09-02 2003-09-02
PCT/US2004/028345 WO2005020963A1 (en) 2003-09-02 2004-09-01 Process for preparing a medicament
EP04782768A EP1699434B1 (en) 2003-09-02 2004-09-01 Process for preparing a medicament

Publications (1)

Publication Number Publication Date
PL1699434T3 true PL1699434T3 (pl) 2011-09-30

Family

ID=34272843

Family Applications (1)

Application Number Title Priority Date Filing Date
PL04782768T PL1699434T3 (pl) 2003-09-02 2004-09-01 Sposób wytwarzania leku

Country Status (12)

Country Link
US (3) US9345664B2 (pl)
EP (1) EP1699434B1 (pl)
AT (1) ATE498394T1 (pl)
CA (1) CA2575957C (pl)
CY (1) CY1113221T1 (pl)
DE (1) DE602004031459D1 (pl)
DK (1) DK1699434T3 (pl)
ES (1) ES2362038T3 (pl)
PL (1) PL1699434T3 (pl)
PT (1) PT1699434E (pl)
SI (1) SI1699434T1 (pl)
WO (1) WO2005020963A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8273331B2 (en) * 2002-08-21 2012-09-25 Norton Healthcare Ltd. Inhalation compositions
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
GB0327723D0 (en) 2003-09-15 2003-12-31 Vectura Ltd Pharmaceutical compositions
AU2004285592B2 (en) * 2003-11-03 2010-02-18 Norton Healthcare, Ltd. Soft steroid compositions for use in dry powder inhalers
CA2597942A1 (en) * 2005-02-16 2006-08-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions comprising anticholinergics and etiprednol

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
US3957965A (en) * 1967-08-08 1976-05-18 Fisons Limited Sodium chromoglycate inhalation medicament
GB1569611A (en) 1976-01-23 1980-06-18 Fisons Ltd Pelletised or granular medicament formulation
US4161516A (en) 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB9027234D0 (en) 1990-12-15 1991-02-06 Harris Pharma Ltd An inhalation device
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
IS1796B (is) 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
SE9400335D0 (sv) 1994-02-02 1994-02-02 Astra Ab Powder mixing
AR002009A1 (es) * 1994-12-22 1998-01-07 Astra Ab Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco.
DE69724420T2 (de) * 1996-04-29 2004-06-09 Quadrant Technologies Ltd. Verfahren zum inhalieren trockener pulver
SE9700135D0 (sv) 1997-01-20 1997-01-20 Astra Ab New formulation
DE10043509A1 (de) * 2000-09-01 2002-03-14 Asta Medica Ag Feste Peptidzubereitungen für die Inhalation und deren Herstellung
UA75375C2 (en) 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DE10141376A1 (de) 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Inhalationspulvern
JP2005507881A (ja) * 2001-09-17 2005-03-24 グラクソ グループ リミテッド 乾燥粉末医薬製剤
US8273331B2 (en) 2002-08-21 2012-09-25 Norton Healthcare Ltd. Inhalation compositions
GB0219512D0 (en) 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios
US20050158248A1 (en) 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions

Also Published As

Publication number Publication date
EP1699434A1 (en) 2006-09-13
US9987229B2 (en) 2018-06-05
US9616024B2 (en) 2017-04-11
US20080131518A1 (en) 2008-06-05
PT1699434E (pt) 2011-05-03
CA2575957C (en) 2010-11-30
EP1699434A4 (en) 2009-04-29
WO2005020963A1 (en) 2005-03-10
CY1113221T1 (el) 2016-04-13
DE602004031459D1 (de) 2011-03-31
ES2362038T3 (es) 2011-06-27
SI1699434T1 (sl) 2011-06-30
US9345664B2 (en) 2016-05-24
ATE498394T1 (de) 2011-03-15
US20170172925A1 (en) 2017-06-22
EP1699434B1 (en) 2011-02-16
DK1699434T3 (da) 2011-05-30
US20160235678A1 (en) 2016-08-18
CA2575957A1 (en) 2005-03-10

Similar Documents

Publication Publication Date Title
TW200720307A (en) Catalyst compositions comprising support materials having an improved particle-size distribution
EP2357046A3 (en) Method of manufacturing an electrode
HK1085495A1 (en) Spherical powder components and solid cosmetic compositions comprising thereof
MXPA02008117A (es) Particulas de ceramica de liberacion controlada composiciones de estas, procesos de su preparacion y metodos de uso.
RS50495B (sr) Postupak za pripremanje preparata u obliku praha
CA2534056A1 (en) Calcium carbonate granulation
CY1113221T1 (el) Διεργασια για την παρασκευη ενος φαρμακου
MX2007005919A (es) Materiales en particulas de alumina de transicion que tienen morfologia controlada, y procesamiento para formar los mismos.
MXPA03001181A (es) Productos de perlita expandida con distribucion controlada de tamano de particula.
ATE220563T1 (de) Nichtklumpende superabsorbierende polymere
CA2430318A1 (en) Powder formulation and method for producing the same
HUP0003095A2 (hu) Tabletta alakú mosószer összesajtolt szemcsékből, valamint eljárás előállítására
MY139949A (en) Carbon block water filter
WO2006085101A3 (en) Pharmaceutical compositions useful in the transmucosal administration of drugs
CA2455261A1 (en) Sprinkling method for preparing powder formulations
AU2001291627A1 (en) Sustained release particle dispersion
WO2003090715A3 (en) Particulate materials
PL349919A1 (en) Method for producing hard metal mixtures
MXPA04003892A (es) Proceso para produccion de granulos de detergente.
ES2171110A1 (es) Composicion farmaceutica a base de ibuprofeno y procedimiento para su preparacion.
WO2002100389A8 (en) Compressible guaifenesin compositions and method for producing them
KR970703711A (ko) 황산콜리스틴을 함유하는 안정화된 조성물(stabilized composition comprising colistin sulfate)
WO2005058473A3 (en) Particulate materials
CA2406592A1 (en) Method of preparing pharmaceutical dosage forms containing multiple active ingredients
JPS62220590A (ja) 粒状燃料の製造法